139 related articles for article (PubMed ID: 15547732)
1. Relationship between immunohistochemical evaluation of thymidylate synthase and proliferating cell nuclear antigen labeling index in gastrointestinal carcinoma.
Kunimoto Y; Nakamura T; Ohno M; Kuroda Y
Oncol Rep; 2004 Dec; 12(6):1163-7. PubMed ID: 15547732
[TBL] [Abstract][Full Text] [Related]
2. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.
Takizawa M; Kawakami K; Obata T; Matsumoto I; Ohta Y; Oda M; Sasaki T; Watanabe G
Oncol Rep; 2006 Jun; 15(6):1533-9. PubMed ID: 16685392
[TBL] [Abstract][Full Text] [Related]
3. Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung.
Hashimoto H; Ozeki Y; Sato M; Obara K; Matsutani N; Nakagishi Y; Ogata T; Maehara T
Cancer; 2006 Apr; 106(7):1595-601. PubMed ID: 16489621
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral heterogeneous expression of thymidylate synthase in gastric cancer.
Chung-Kang C; Ohno M; Nishimura K; Kuroda Y
Hepatogastroenterology; 2006; 53(69):458-62. PubMed ID: 16795992
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between expression of thymidylate synthase and colorectal carcinoma].
Yu ZG; Sun JZ; Zhang Q; Jia HY; Wang JX
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1432-5. PubMed ID: 15500737
[TBL] [Abstract][Full Text] [Related]
6. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
[TBL] [Abstract][Full Text] [Related]
7. Acceleration of the proliferative activity of esophageal carcinoma with invasion beyond the muscularis mucosae; immunohistochemical analysis using MIB-1 for the Ki-67 antigen.
Chino O; Osamura Y; Kise Y; Nishi T; Shimada H; Tanaka M; Kijima H; Makuuchi H
Tokai J Exp Clin Med; 2007 Dec; 32(4):115-20. PubMed ID: 21318949
[TBL] [Abstract][Full Text] [Related]
8. [The evaluation of cellular proliferating activity in gastric carcinoma with the proliferating cell nuclear antigen (PCNA) expressive rate: its fundamental examination of the immunohistochemical procedures and its clinical applications].
Nakano H; Namatame K; Nakayoshi A; Kumada K
Nihon Geka Gakkai Zasshi; 1993 Jun; 94(6):580-92. PubMed ID: 8101959
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of thymidylate synthase as a prognostic factor and as a chemotherapeutic efficacy index in patients with colorectal carcinoma.
Tachikawa D; Arima S; Futami K
Anticancer Res; 2000; 20(6A):4103-7. PubMed ID: 11131679
[TBL] [Abstract][Full Text] [Related]
10. [Effect of low dose CDDP/5-fluorouracil therapy on PCNA labeling index and TS inhibition rate of gastric cancer].
Kosaka T; Sugaya J; Yoshida S; Takano Y; Nakano Y; Akiyama T; Kiriyama M; Tomita F; Saito H; Kita I
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():205-8. PubMed ID: 7611790
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study.
Terada T; Ohta T; Kitamura Y; Ashida K; Matsunaga Y
Arch Pathol Lab Med; 1998 Jan; 122(1):42-6. PubMed ID: 9448015
[TBL] [Abstract][Full Text] [Related]
12. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
[TBL] [Abstract][Full Text] [Related]
13. Expression of proliferating cell nuclear antigen(PCNA) in biopsy and autopsy specimens of gastric carcinoma.
He XB; Ii K; Muguruma N; Hayashi S; Ito S
J Med Invest; 1998 Feb; 44(3-4):149-53. PubMed ID: 9597802
[TBL] [Abstract][Full Text] [Related]
14. Do proliferating cell nuclear antigen and MIB-1/Ki-67 have prognostic value in penile squamous cell carcinoma?
Guimarães GC; Leal ML; Campos RS; Zequi Sde C; da Fonseca FP; da Cunha IW; Soares FA; Lopes A
Urology; 2007 Jul; 70(1):137-42. PubMed ID: 17656224
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of proliferating cell nuclear antigen (PCNA) in supraglottic carcinoma.
Liu M; Lawson G; Delos M; Jamart J; Remacle M
Acta Otorhinolaryngol Belg; 1997; 51(3):129-35. PubMed ID: 9350310
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of proliferative cell nuclear antigen expression and clinical prognosis in gastric malignant lymphoma].
Tsurumachi T; Gunji S; Suzuki T; Nagata M; Nakajima K; Matsubara H; Koide Y; Ochiai T; Isono K
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1781-5. PubMed ID: 8937488
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen immunostaining in breast carcinoma and its relationship to clinical and pathological variables.
Agarwal S; Jain R; Rusia U; Gupta RL
Indian J Pathol Microbiol; 1997 Jan; 40(1):11-6. PubMed ID: 9145605
[TBL] [Abstract][Full Text] [Related]
19. Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasis.
Marsh S; McKay JA; Curran S; Murray GI; Cassidy J; McLeod HL
Oncol Rep; 2002; 9(2):231-4. PubMed ID: 11836585
[TBL] [Abstract][Full Text] [Related]
20. Proliferating nuclear antigen (PCNA) as a prognostic factor of squamous cell carcinoma of the oesophagus.
Dabrowski A; Szumiło J; Brajerski G; Wallner G
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():59-67. PubMed ID: 11977365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
